Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
ANNUAL INCOME RANGE
BANK MODIFICATION
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
Hikal Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value(
)
524735
INE475B01022
97.5874153
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
HIKAL
63.59
4735.98
EPS(TTM)
Face Value(
)
Div & Yield %:
6.04
2
0.31
Back
Oil India Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 14,2025
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that the Company will participate in Chasing the Growth an Investor Meet organised by Kotak Securities Limited in Mumbai on 20th February 2025. The Meeting is scheduled for Investor Group